A stock market site by Business Insider with real-time data, custom charts and breaking news. Get the latest on stocks, commodities, currencies, funds, rates, ETFs, and more.

  • 31,383articles · 365d
  • 8+ hour agolatest article
  • Sep 14, 2025earliest in window
  • 93%with images
  • 290avg words
articles per day
Categories
  • Economy, Business & Finance 26,599
  • Finance & Business 22,236
  • News 10,076
  • Finance 4,949
  • Business & Industrial 4,917
  • Health & Wellness 3,722
  • Medical 2,567
  • Computers & Electronics 1,146

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

markets.businessinsider.com
markets.businessinsider.com > news > stocks > the-neck-cloud-announces-cervical-decompression-device-for-tech-neck-neck-pain-1036242893

The Neck Cloud Announces Cervical Decompression Device For Tech Neck & Neck Pain

3+ mon, 2+ day ago   (360+ words) markets.businessinsider.com The Neck Cloud Announces Cervical Decompression Device For Tech Neck & Neck Pain The Neck Cloud has announced a cervical traction device designed to address tech neck in desk workers through a three-way system combining cervical traction, acupressure,…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > electrocore-announces-publication-in-jama-highlighting-the-benefits-of-adding-quell-electrical-nerve-stimulation-to-outpatient-physical-therapy-in-fibromyalgia-1036149620

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

4+ mon, 4+ hour ago   (177+ words) electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > bone-drs-orthopedic-care-addresses-surging-demand-for-minimally-invasive-knee-replacement-in-central-texas-1036157152

Bone Drs Orthopedic Care Addresses Surging Demand for Minimally Invasive Knee Replacement in Central Texas

3+ mon, 4+ week ago   (311+ words) Traditional knee replacement surgery often comes with long recovery times. It can make treatment feel overwhelming for some patients. Bone Drs Orthopedic Care offers advanced minimally invasive knee replacement options to help Central Texas residents return to active living without…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > cervical-traction-device-for-neck-pain-tmj-tension-headaches-product-updated-1036125600

Cervical Traction Device For Neck Pain, TMJ & Tension Headaches: Product Updated

4+ mon, 5+ day ago   (422+ words) markets.businessinsider.com Cervical Traction Device For Neck Pain, TMJ & Tension Headaches: Product Updated The Neck Cloud has updated its lab-tested cervical traction device with a three-way system combining cervical traction, acupressure, and sub-occipital muscle stimulation — developed over three years…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > featol-introduces-back-brace-support-belt-for-everyday-lower-back-support-1036106534

FEATOL Introduces Back Brace Support Belt for Everyday Lower Back Support

4+ mon, 1+ week ago   (439+ words) NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Lower back pain is becoming increasingly common in daily life, with more than one in four U.S. adults reporting ongoing discomfort. As more people look for ways to stay active without letting pain disrupt their routines,…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > liberty-physical-therapy-wellness-celebrates-15-years-of-serving-jersey-city-with-integrated-patient-centered-care-1036094447

Liberty Physical Therapy & Wellness Celebrates 15 Years of Serving Jersey City with Integrated, Patient-Centered Care

4+ mon, 1+ week ago   (377+ words) Jersey City’s top-rated PT clinic celebrates a 15-year milestone of delivering personalized,non-surgical physical therapy to patients of all ages Jersey City, NJ, May 1, 2026 -- Liberty Physical Therapy & Wellness is proud to celebrate 15 years of providing comprehensive physical therapy in Jersey…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > physical-rehabilitation-network-memorialcare-open-new-outpatient-physical-therapy-clinic-in-garden-grove-1036089624

Physical Rehabilitation Network & MemorialCare Open New Outpatient Physical Therapy Clinic in Garden Grove

4+ mon, 1+ week ago   (215+ words) Opening at 11869 Valley View St., the clinic will carry PRN's long-trusted local brand, California Rehabilitation and Sports Therapy (Cal Rehab). Patients of all ages will find a full range of services under one roof, including pre- and post-operative rehab, non-surgical…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > biorestorative-therapies-to-present-new-data-at-isct-2026-highlighting-its-ongoing-phase-2-clinical-trial-in-chronic-lumbar-disease-and-its-biocosmeceutical-platform-1036087380

BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform

4+ mon, 1+ week ago   (420+ words) BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform Data demonstrate progress in each of its MSC-derived programs MELVILLE, N.Y., April 30, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative," "BRTX,…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > artelo-announces-peer-reviewed-publication-supporting-its-fabp5-inhibitor-art26-12-as-a-novel-pain-treatment-with-a-potentially-first-in-class-profile-1036037571

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

4+ mon, 3+ week ago   (229+ words) Demonstrates ART26.12’s Differentiated Profile as a Promising Pain Treatment Ahead of Planned Multiple Ascending Dose Study This Year Phase 1 SAD Study Exhibited Excellent Safety with Zero Adverse Events Attributed to ART26.12 These findings are supported by a broader body of evidence…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > mesoblast-achieves-patient-recruitment-target-in-pivotal-phase-3-trial-for-chronic-low-back-pain-1036074660

Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain

4+ mon, 2+ week ago   (421+ words) The placebo-controlled study (MSB-DR004) will follow at least 300 patients randomized to a single intra-discal injection of rexlemestrocel-L or sham control for 12 months. The trial seeks to confirm results from the earlier MSB-DR003 trial where a single intra-discal injection of rexlemestrocel-L…...